Sorrento Therapeutics Inc (SRNE)

1.65
NASDAQ : Health Care
Prev Close 1.65
Day Low/High 0.00 / 0.00
52 Wk Low/High 1.55 / 8.35
Avg Volume 840.60K
Exchange NASDAQ
Shares Outstanding 75.31M
Market Cap 124.26M
EPS -1.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Sorrento Therapeutics Anti-CEA CAR-T Demonstrates Promising Clinical Activity And Safety In Phase Ib Clinical Trial

- This is the second trial to demonstrate the safety and tolerability of our anti-CEA CAR-T hepatic artery infusions in heavily pre-treated, unresectable, chemotherapy refractory patients

Sorrento And Wildcat Announce Resolution

Sorrento Therapeutics Becomes Oversold (SRNE)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Biotech Premarket Movers: Cytokinetics, Artana Therapeutics, Bluebird

Biotech Premarket Movers: Cytokinetics, Artana Therapeutics, Bluebird

Shares of late-stage biopharma Cytokinetics increased following positive comments from an Needham analyst.

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Investments, LLC today announced the result of the semi-annual rebalance and reconstitution of the Loncar Cancer Immunotherapy Index, a group of the top 30 companies developing cancer immunotherapy treatments and...

Oversold Conditions For Sorrento Therapeutics (SRNE)

Oversold Conditions For Sorrento Therapeutics (SRNE)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Sorrento's TNK Therapeutics Provides Progress Update For Its Anti-CD38 And CD123 CAR-T Programs For Treatment Of Hematological Malignancies

Sorrento's TNK Therapeutics Provides Progress Update For Its Anti-CD38 And CD123 CAR-T Programs For Treatment Of Hematological Malignancies

- Novel Anti-CD38 CAR-T and Anti-CD123 CAR-T Programs Utilizing Sorrento's Fully Human Antibodies Demonstrated Strong Anti-Tumor Activity in Preclinical Models of Multiple Myeloma and Acute Myeloid Leukemia, respectively

Sorrento's TNK Therapeutics Subsidiary To Acquire Virttu Biologics

Sorrento's TNK Therapeutics Subsidiary To Acquire Virttu Biologics

- Lead Product Candidate Seprehvir® Ready for Phase II Trials

Sorrento Therapeutics Closes Acquisition Of Scilex

Sorrento Therapeutics Closes Acquisition Of Scilex

- FDA Feedback Provides Clear Guidance for ZTLido™ NDA Resubmission

Noteworthy Tuesday Option Activity: SRNE, RAIL, FEYE

Noteworthy Tuesday Option Activity: SRNE, RAIL, FEYE

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sorrento Therapeutics Inc , where a total of 1,252 contracts have traded so far, representing approximately 125,200 underlying shares. That amounts to about 51.1% of SRNE's average daily trading volume over the past month of 244,825 shares.

Tax-Loss Selling Offers Stock-Picking Opportunities

Our screen reveals 17 names that could become oversold and disconnected from their fundamentals as a result of this phenomenon.

Sorrento Therapeutics Enters Oversold Territory (SRNE)

Sorrento Therapeutics Enters Oversold Territory (SRNE)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Lack of Catalysts Keeps Analysts Away From Pfizer

Lack of Catalysts Keeps Analysts Away From Pfizer

Pfizer may not be the best investment in coming months, as doubts surface about the company's near-term prospects in the absence of M&A.

Noteworthy Monday Option Activity: SRNE, GNE, KBH

Noteworthy Monday Option Activity: SRNE, GNE, KBH

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sorrento Therapeutics Inc , where a total of 1,207 contracts have traded so far, representing approximately 120,700 underlying shares. That amounts to about 49.4% of SRNE's average daily trading volume over the past month of 244,400 shares.